

share
Omalizumab CAS NO 242138-07-4
Unit Price:
CAS No.:242138-07-4
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Omalizumab is a recombinant DNA-derived humanized monoclonal antibody that selectively binds to immunoglobulin E (IgE). This product is a critical active pharmaceutical ingredient (API) used in the formulation of targeted biologic therapies. It is essential for pharmaceutical manufacturers and research institutions developing treatments for allergic asthma and chronic idiopathic urticaria. Our supply of Omalizumab CAS NO 242138-07-4 ensures high purity and reliable consistency for advanced therapeutic applications.
Application
- Pharmaceutical API: Primary ingredient in the manufacture of biologic drugs for treating moderate to severe persistent allergic asthma.
- Biologic Formulation: Used in the development and production of injectable solutions for targeted immunotherapy.
- Clinical Research: Serves as a key reference standard and material in preclinical and clinical studies for IgE-mediated disorders.
- Biosimilar Development: Critical for companies engaged in the research, development, and analytical testing of biosimilar products.
- Specialty Medicine Production: Formulated into final drug products for patients with chronic spontaneous urticaria (CSU).
Basic Information
| Product Name | Omalizumab |
| CAS No. | 242138-07-4 |
| Molecular Formula | C6450H9916N1714O2017S44 |
| Molecular Weight | Approx. 149 kDa |
| Synonyms | rhuMAb-E25; Anti-Human Immunoglobulin E Recombinant Monoclonal Antibody; Xolair (Trade Name); Immunoglobulin E Humanized Monoclonal Antibody; IgE Inhibitor; Olizumab; E-25; rhuMAb E25 |
| EINECS | Contact for details |
Quality Control
Our Omalizumab is manufactured and tested under strict quality systems. Each batch is subjected to a comprehensive battery of analytical tests including HPLC for purity and potency, SDS-PAGE and CE-SDS for identity and impurity profile, and biological activity assays to ensure it meets the stringent requirements for pharmaceutical use. Certificates of Analysis (COA) with full traceability are provided, confirming compliance with relevant cGMP guidelines.
Storage
Preserve in a tightly closed container, protected from light. Store at 2-8°C. This product is hygroscopic (moisture-sensitive) and must be kept under controlled conditions to maintain stability. For long-term storage, keep desiccated.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or solid |
| Identification (HPLC/MS) | Conforms to reference standard |
| Purity (SEC-HPLC) | ≥ 98.0% (Monomer) |
| Protein Content (UV) | 95.0% - 105.0% of label claim |
| Biological Activity (ELISA/Binding) | ≥ 90% of reference standard |
| Endotoxin (LAL) | < 1.0 EU/mg |
| Host Cell Proteins (HCP ELISA) | < 100 ppm |
| Residual DNA (qPCR) | < 10 pg/mg |
| Moisture Content (KF) | < 3.0% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Bovine Albumin CAS NO 9048-46-8


Albumin From Chicken Egg White CAS NO 9006-59-1


Melanotan-1 CAS NO 75921-69-6


Dermorphin CAS NO 77614-16-5


Dsip CAS NO 62568-57-4


Epitalon CAS NO 307297-39-8


Humanin CAS NO 330936-69-1


H-Gly-Pro-Hyp-Oh CAS NO 2239-67-0


Lactoferrin CAS NO 146897-68-9


Ll-37 CAS NO 154947-66-7


Selank Peptide CAS NO 129954-34-3


Holo-Transferrin CAS NO 11096-37-0


Hyaluronidase CAS NO 37326-33-3


Neuropeptide S (1-10) (Human) CAS NO 904910-39-0


Doreptide CAS NO 90104-48-6


Hirsutide CAS NO 865368-30-5


Nph-Peptide CAS NO 84311-50-2


n-Acetyl-Phe-Octreotide CAS NO 83795-61-3


Ha Peptide CAS NO 92000-76-5


Transdermal Peptide CAS NO 918629-48-8
why choose us
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






